Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
WAC | NUH | 01/03/16 | 6 | 5.9K | |||
|
|||||||
WAC | Ann: Reinstatement to Official Quotation (02/03/2016) | 01/03/16 | 1 | 1.4K | |||
|
|||||||
WAC | Ann: Closure of Prospectus Offer | 29/02/16 | 21 | 10K | |||
|
|||||||
WAC | Ann: Appendix 3B | 29/02/16 | 0 | 811 | |||
|
|||||||
WAC | The Honorable Steven Ciobo, Australia’s Minister for Trade and Investment! | 29/02/16 | 2 | 1.5K | |||
|
|||||||
WAC | Ann: Employee Share Option Plan Rules | 29/02/16 | 0 | 877 | |||
|
|||||||
WAC | Ann: Updated Proforma Balance Sheet | 29/02/16 | 0 | 819 | |||
|
|||||||
WAC | Ann: Updated Statement of Commitments | 29/02/16 | 0 | 1.0K | |||
|
See All Discussions